DPP4 and metabolic disease: These results may lead to different interpretations: on the one hand, they could reflect a direct role of DPP4 in hepatic damage in the presence of metabolic diseases, i.e., in the course of NAFLD/NASH, or at least a potential role of DPP4 as a biomarker of hepatic injury.